
    
      This is an observational (study in which participants identified as belonging to study groups
      are assessed for biomedical or health outcomes), longitudinal (correlational research study
      that involves repeated observations of the same variables over long periods of time) and
      retrospective (study looking back over past experience) study to describe the treatment
      patterns in mCRPC. Treatment patterns will be assessed by collecting medical charts from
      participants diagnosed with mCRPC in or prior 2009. Primarily, percentage of participants who
      received therapy as first line treatment will be assessed. All adverse events associated with
      the use of Sponsor drugs will be reported.
    
  